title: PSA after definitive radiotherapy for clinically localized prostate cancer.
abstract: A rising PSA level for clinically localized prostate cancer after definitive radiotherapy is an ominous finding that correlates with positive postirradiation biopsy and traditional clinical progression. The study detailed in this article found that the proportion of patients treated with radiotherapy who achieved stable PSA levels and were clinically free of disease was disappointingly low.
authors.affiliation: Scott Department of Urology, Baylor College of Medicine, Houston, Texas.
authors.forename: J R
authors.initials: JR
authors.lastname: Goad
authors.forename: S J
authors.initials: SJ
authors.lastname: Chang
authors.forename: M
authors.initials: M
authors.lastname: Ohori
authors.forename: P T
authors.initials: PT
authors.lastname: Scardino
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000532:radiotherapy*
chemical_list: D017430:Prostate-Specific Antigen